Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.19 is 46% above its 5-year average of -2.21, near the high end of its 5-year range (-3.96–-0.35).
55.68% above its 12-month average of -2.69.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.46.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:52:31.886Z. Historical observations retain their original dates. Historical series through 2019-11-05.
EARNINGS PER SHARE (EPS)
-1.19
EARNINGS PER SHARE (EPS) AVG TTM
-2.69
EARNINGS PER SHARE (EPS) AVG 3Y
-2.49
EARNINGS PER SHARE (EPS) AVG 5Y
-2.21
EARNINGS PER SHARE (EPS) AVG 10Y
-1.08
EARNINGS PER SHARE (EPS) AVG 15Y
-0.26
EARNINGS PER SHARE (EPS) AVG 20Y
-0.10
CURRENT VS TTM AVG
+55.68%
CURRENT VS 3Y AVG
+52.11%
CURRENT VS 5Y AVG
+46.23%
CURRENT VS 10Y AVG
-9.98%
CURRENT VS 15Y AVG
-355.23%
CURRENT VS 20Y AVG
-1082.97%
Myriad Genetics, Inc.
Market Cap
$404.24M
Earnings Per Share (EPS)
-1.19
TTM Avg
-2.69
3Y Avg
-2.49
5Y Avg
-2.21
Market Cap
$405.74M
Earnings Per Share (EPS)
-2.08
TTM Avg
-1.97
3Y Avg
-1.74
5Y Avg
-0.94
Market Cap
$402.17M
Earnings Per Share (EPS)
-5.51
TTM Avg
-4.26
3Y Avg
-3.91
5Y Avg
-2.87
Market Cap
$406.58M
Earnings Per Share (EPS)
-4.63
TTM Avg
-6.16
3Y Avg
-6.16
5Y Avg
-6.16
Market Cap
$397.99M
Earnings Per Share (EPS)
-1.36
TTM Avg
-1.81
3Y Avg
-2.62
5Y Avg
-2.62
Market Cap
$411.00M
Earnings Per Share (EPS)
0.50
TTM Avg
0.08
3Y Avg
-0.25
5Y Avg
-0.31
Market Cap
$411.21M
Earnings Per Share (EPS)
-5.18
TTM Avg
-2.77
3Y Avg
-1.90
5Y Avg
-1.90
Market Cap
$396.93M
Earnings Per Share (EPS)
-1.71
TTM Avg
-1.36
3Y Avg
-1.12
5Y Avg
-1.12
Market Cap
$415.98M
Earnings Per Share (EPS)
-0.76
TTM Avg
-0.86
3Y Avg
-1.02
5Y Avg
-1.51
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Myriad Genetics, Inc. (MYGN) | $404.24M | -1.19 | -2.69 | -2.49 | -2.21 |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $405.74M | -2.08 | -1.97 | -1.74 | -0.94 |
| Neurogene Inc. (NGNE)vs › | $402.17M | -5.51 | -4.26 | -3.91 | -2.87 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $406.58M | -4.63 | -6.16 | -6.16 | -6.16 |
| Carlsmed, Inc. (CARL)vs › | $397.99M | -1.36 | -1.81 | -2.62 | -2.62 |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.00M | 0.50 | 0.08 | -0.25 | -0.31 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | -5.18 | -2.77 | -1.90 | -1.90 |
| Shoulder Innovations, Inc. (SI)vs › | $396.93M | -1.71 | -1.36 | -1.12 | -1.12 |
| Rezolute, Inc. (RZLT)vs › | $415.98M | -0.76 | -0.86 | -1.02 | -1.51 |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | -2.27 | -2.08 | -0.07 | -5.01 |
Trailing EPS (TTM)
$-1.19
Forward EPS (Est.)
$-0.72
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -3.96 |
| 2024-12-31 | -1.41 |
| 2023-12-31 | -3.18 |
| 2022-12-31 | -1.39 |
| 2021-12-31 | -0.35 |
| 2020-12-31 | -2.99 |
| 2020-06-30 | -2.69 |
| 2019-06-30 | 0.06 |
| 2018-06-30 | 1.89 |
| 2017-06-30 | 0.32 |
| 2016-06-30 | 1.79 |
| 2015-06-30 | 1.12 |
| 2014-06-30 | 2.33 |
| 2013-06-30 | 1.82 |
| 2012-06-30 | 1.33 |
| 2011-06-30 | 1.12 |
| 2010-06-30 | 1.58 |
| 2009-06-30 | 0.91 |
| 2008-06-30 | 0.54 |
| 2007-06-30 | -0.43 |
| 2006-06-30 | -0.53 |
| 2005-06-30 | -0.65 |
| 2004-06-30 | -0.74 |
| 2003-06-30 | -0.48 |
| 2002-06-30 | -0.30 |
| 2001-06-30 | -0.16 |
| 2000-06-30 | -0.22 |
| 1999-06-30 | -0.27 |
| 1998-06-30 | -0.26 |
| 1997-06-30 | -0.26 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-06T21:52:31.886Z. Historical observations retain their original dates. Historical series through 2019-08-13.
